WILLIAM SPARKS: Open Payments
NPI 1366040503 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 11 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $182 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $41 |
| GENZYME CORPORATION | 1 | $30 |
| Incyte Corporation | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| SOBI, INC | 1 | $22 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Syndax Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: VENCLEXTA, WAYRILZ, JAKAFI, ULTOMIRIS, Vonjo, TAVALISSE, ELREXFIO, PREVYMIS.
Industry payments across NC — which companies pay providers there.
